BLU2864
BLU2864 is a potent and selective ATP-competitive inhibitor of PRKACA (IC50 = 0.3 nM) . It demonstrates anti-tumor activity in preclinical research, supporting its investigation for applications in oncology and polycystic kidney disease models, both in vitro and in vivo.
Product Specifications
CAS Number
2810747-89-6
Product Name Alternative
BLU 2864, BLU2864, BLU-2864, PRKACA
Field of Research
Signal Transduction
Purity
97.58% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.42 mM) ; DMSO:50 mg/mL (110.51 mM)
Smiles
N (C (=O) C=1C=CC (=NC1) C2=C3C (NC=C3C) =NC=C2) [C@@H]4C=5C (=CC (C (F) F) =CC5F) C[C@@H]4O
Molecular Formula
C24H19F3N4O2
Molecular Weight
452.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
CSB-YP011670MO-01 20 µg
Recombinant Mouse Interleukin-7 receptor subunit alpha (Il7r), partial
Sign In for Pricing
View Details